White label ELPA - ClinicalTrials.eu

Comparing mirikizumab versus azathioprine with glucocorticoids in newly diagnosed patients with moderate-to-severe ulcerative colitis

Recruiting

3 1 1 1
Investigated diseases:
- Colitis ulcerative
Investigated drugs:
- Azathioprine
- Mirikizumab
Study of BGB-16673 in combination with drug therapy for patients with relapsed or refractory B-cell malignancies

Recruiting

1 1 1 1
Investigated diseases:
Investigated drugs:
Long-term safety study of tulisokibart in adults with Crohn’s disease or ulcerative colitis

Recruiting

3 1
Investigated diseases:
- Colitis ulcerative
- Crohn’s disease
Investigated drugs:
- Tulisokibart
Study Comparing the Safety and Effectiveness of Mexiletine PR and Mexiletine IR for Adults with Non-Dystrophic Myotonias

Recruiting

3 1 1 1
Investigated diseases:
- Myotonic dystrophy
Investigated drugs:
- Mexiletine
- Mexiletine Hydrochloride
Study of milsaperidone as an additional treatment for adults with Major Depressive Disorder who are already taking antidepressants

Recruiting

3 1
Investigated diseases:
- Major depression
Investigated drugs:
- (1S)-1-[4-[3-[4-(6-FLUORO-1,2-BENZOXAZOL-3-YL)PIPERIDIN-1-YL]PROPOXY]-3-METHOXYPHENYL]ETHANOL
Evaluation of nandrolone decanoate treatment combined with physiotherapy and diet in elderly patients with sarcopenia

Recruiting

2 1 1 1
Investigated drugs:
- Nandrolone Decanoate
- Sodium Chloride
Long-Term Safety and Efficacy Study of Mexiletine Hydrochloride for Patients with Myotonic Dystrophy Type 1 and Type 2

Recruiting

3 1 1
Investigated diseases:
- Myotonic dystrophy
Investigated drugs:
- Mexiletine Hydrochloride
Study on the Effects of Mexiletine for Treating Myotonic Dystrophy Types 1 and 2 in Patients

Recruiting

3 1
Investigated drugs:
- Mexiletine Hydrochloride
Long-term safety study of eptinezumab given by intravenous infusion for children and adolescents aged 6-17 years with chronic or episodic migraine

Recruiting

3 1 1 1
Investigated diseases:
- Migraine
Investigated drugs:
- Eptinezumab
Safety Study of Regulatory T Cells (Treg02) in Patients After Kidney Transplant

Recruiting

1 1 1 1
Investigated diseases:
- Renal transplant
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies